The MSCs were assessed by RNA sequencing for expression of ACE2 or TMPRSS2 prior to administration and each was found to be minimally expressed (in one out of 12 500 cells and seven out of 12 500 cells, respectively), although the RNA sequencing results were not validated for gene (quantitative reverse transcription PCR) or protein expression.